NasdaqCM - Nasdaq Real Time Price USD
Immunome, Inc. (IMNM)
8.50
+0.31
+(3.79%)
At close: April 23 at 4:00:01 PM EDT
8.22
-0.28
(-3.29%)
Pre-Market: 4:18:31 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.57 | -0.56 | -2.3 | -2.64 |
| Low Estimate | -0.66 | -0.67 | -2.62 | -3.32 |
| High Estimate | -0.47 | -0.4 | -1.71 | -1.66 |
| Year Ago EPS | -2.51 | -0.6 | -5 | -2.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 457.14k | 457.14k | 1.94M | 15.28M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 3.2M | 3.2M | 9.13M | 51.92M |
| Year Ago Sales | 1.03M | 2.36M | 9.04M | 1.94M |
| Sales Growth (year/est) | -55.57% | -80.66% | -78.53% | 686.79% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.4 | -0.58 | -0.61 |
| EPS Actual | -2.51 | -0.6 | -0.78 | -1.11 |
| Difference | -2.06 | -0.2 | -0.2 | -0.5 |
| Surprise % | -457.78% | -50.00% | -33.72% | -82.72% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.57 | -0.56 | -2.3 | -2.64 |
| 7 Days Ago | -0.62 | -0.61 | -2.41 | -2.78 |
| 30 Days Ago | -0.69 | -0.69 | -2.62 | -2.71 |
| 60 Days Ago | -0.69 | -0.69 | -2.62 | -2.71 |
| 90 Days Ago | -0.58 | -0.58 | -2.45 | -2.19 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 1 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMNM | 77.21% | 6.33% | 54.08% | -15.16% |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Initiated | Lake Street: Buy | 4/2/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 3/20/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/20/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/20/2025 |
| Initiated | LifeSci Capital: Outperform | 3/11/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/14/2024 |
Related Tickers
SWTX SpringWorks Therapeutics, Inc.
41.21
+1.75%
IMNN Imunon, Inc.
0.8766
+0.53%
COGT Cogent Biosciences, Inc.
4.4700
+3.00%
JANX Janux Therapeutics, Inc.
31.62
+5.36%
TRML Tourmaline Bio, Inc.
17.82
+2.89%
KURA Kura Oncology, Inc.
6.37
+0.95%
APLS Apellis Pharmaceuticals, Inc.
17.49
+0.69%
AKRO Akero Therapeutics, Inc.
39.61
+2.88%
IMVT Immunovant, Inc.
14.45
+1.40%
BCYC Bicycle Therapeutics plc
8.67
-0.69%